Zendesk, Inc. (ZEN) Reaches $37.51 After 7.00% Up Move; Curis (CRIS)’s Sentiment Is 1.48

January 14, 2018 - By Linda Rogers

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company has market cap of $120.59 million. The firm develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for relapsed or refractory diffuse large B-cell lymphoma, as well as in Phase I clinical trials for patients with solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trials in patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in preclinical stage for the treatment of hematologic cancers; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. It currently has negative earnings. It is also developing Erivedge, an orally-administered small molecule hedgehog pathway inhibitor for advanced basal cell carcinoma, idiopathic pulmonary fibrosis, and myelofibrosis.

The stock of Zendesk, Inc. (NYSE:ZEN) is a huge mover today! The stock increased 4.11% or $1.48 during the last trading session, reaching $37.51. About 1.06M shares traded or 34.62% up from the average. Zendesk, Inc. (NYSE:ZEN) has risen 6.73% since January 14, 2017 and is uptrending. It has underperformed by 9.97% the S&P500.The move comes after 7 months positive chart setup for the $3.81 billion company. It was reported on Jan, 14 by Barchart.com. We have $40.14 PT which if reached, will make NYSE:ZEN worth $266.56 million more.

Cormorant Asset Management Llc holds 0.3% of its portfolio in Curis, Inc. for 1.15 million shares. First Eagle Investment Management Llc owns 26.51 million shares or 0.09% of their US portfolio. Moreover, Focused Wealth Management Inc has 0.09% invested in the company for 185,513 shares. The Massachusetts-based Bain Capital Public Equity Management Llc has invested 0.06% in the stock. Perceptive Advisors Llc, a New York-based fund reported 951,201 shares.

The stock increased 4.86% or $0.0341 during the last trading session, reaching $0.7354. About 2.00 million shares traded or 23.81% up from the average. Curis, Inc. (CRIS) has risen 2.47% since January 14, 2017 and is uptrending. It has underperformed by 14.23% the S&P500.

Analysts await Curis, Inc. (NASDAQ:CRIS) to report earnings on March, 8. They expect $-0.09 EPS, down 12.50% or $0.01 from last year’s $-0.08 per share. After $-0.11 actual EPS reported by Curis, Inc. for the previous quarter, Wall Street now forecasts -18.18% EPS growth.

Zendesk, Inc., a software development company, provides software-as-a-service products for organizations. The company has market cap of $3.81 billion. The Company’s flagship product includes Zendesk Support, a system for tracking, prioritizing, and solving customer support tickets across various channels. It currently has negative earnings. The firm also offers Zendesk Chat, a live chat software to connect with clients on Websites, in applications, and on mobile devices; Zendesk Talk, a cloud call center software; Zendesk Help Center, a self-service destination with articles, interactive forums, and community; Zendesk Message, a customer messaging software; Zendesk Explore that makes customer data accessible across an organization; and Zendesk Connect, a customer intelligence software.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>